Can we better predict kidney damage from cancer therapies?
A team at the University of Bristol, has been awarded a Translation Accelerator Kidney Award (TAKA) of £90,000 to develop a test that could help identify kidney-damaging cancer drugs earlier, helping make new treatments safer for patients. Read the article…